Biodexa Pharmaceuticals Plc (BDRX)
1.12
+0.01
(+0.90%)
USD |
NASDAQ |
May 07, 09:34
Biodexa Pharmaceuticals Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Adaptimmune Therapeutics PLC | 33.21M |
NuCana PLC | 8.519M |
Autolus Therapeutics PLC | 25.16M |
Mereo BioPharma Group PLC | -- |
Bicycle Therapeutics PLC | 34.86M |